Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,089
Total Claims
$1.8M
Drug Cost
626
Beneficiaries
$2,855
Cost/Patient
Risk Score Breakdown 55/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,536 Allergy/ Immunology providers
-19%
Cost per patient vs peers
$2,855 vs $3,515 avg
-47%
Brand preference vs peers
14.3% vs 27.3% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.2%
Opioid Rate
637
Opioid Claims
$11K
Opioid Cost
5.2%
Long-Acting Rate
Brand vs Generic
Brand: 2,861 claims · $1.4M
Generic: 17,083 claims · $388K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 636 | $171K |
| Immun Glob G(Igg)/Gly/Iga Ov50 | 17 | $92K |
| Fluticasone/Umeclidin/Vilanter | 77 | $54K |
| Rivaroxaban | 190 | $51K |
| Dupilumab | 13 | $50K |
| Rifaximin | 30 | $39K |
| Insulin Glargine,hum.Rec.Anlog | 108 | $36K |
| Budesonide/Formoterol Fumarate | 65 | $34K |
| Fluticasone/Vilanterol | 47 | $29K |
| Insulin Aspart | 89 | $26K |
| Potassium Chloride | 678 | $22K |
| Insulin Detemir | 100 | $22K |
| Linaclotide | 39 | $21K |
| Dextromethorphan Hbr/Quinidine | 30 | $19K |
| Sitagliptin Phosphate | 54 | $16K |
Prescribing Profile
Patient Profile
75
Avg Age
70%
Female
2.27
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About